1 Result(s)

Article

A 71-year-old male with a life-threatening recurrence of hemolytic anemia, thrombocytopenia, and acute kidney injury after pembrolizumab therapy: a case report

Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment. However, their use has been restricted in patients with preexisting autoimmune diseases due to concerns about increased risk of immune-...

**n Zhang, Bi-xia Gao, Cui-yan Guo, Tao Su in BMC Geriatrics (2023)